JuiceCrewAllStar
Whole Milk Drinker
- Joined
- Feb 4, 2014
- Messages
- 37,569
- Reaction score
- 10,368
the real answer is not to smoke weed before I go to bed every night
one challenge I have is that I have a sore throat in the morning pretty much every day of my life so that is not a helpful guiding symptom
the real answer is not to smoke weed before I go to bed every night
i know this feel. chronic sinusitis sucks.
By this logic nobody can isolate in any quarantine scenario.
Maybe stop sucking so many dicks?
The first one of my IRL friends just tested positive and it's not looking good for the dude. He's late 30s, but he's north of 3 bills and a total healthcare disaster.
Damn that sucks, I now know quite a few people to have it. All of them had mild-mid range symptoms.
One of my friends working as a traveler in Florida just got it. She got it from working at the hospital and the hospital is refusing to pay her from time off due to CoVid. Fucking eh.
AztraZeneca vaccine looks less efficacious than the other two we've seen so far...
The hilarious (to me) takeaway is that it is still very positive news because we'll just use that vaccine on the rest of the world. It's not good enough for us to use in the USA, but it's fine for everyone else.
All that said, it feels like people will start receiving these vaccines in December and we should hit herd immunity levels somewhere between late spring and early fall 2021 (huge window).
The AZ vaccine could hit 90% effectiveness based on how it is given. The cost and distribution costs are also much less for this vaccine, and there is already a worldwide distribution plan, which is critical.
It could, but it is more likely that it falls somewhere in between the 62%-90% window... Not a ton of transparency was given on the results.
The half dose + full dose regimen that had higher efficacy (relative to full dose + full dose) had a much smaller number of participants.
It also just doesn't make intuitive sense that half dose + full dose would work materially better than full dose + full dose. The actual number is likely somewhere in between 62%-90%.
It could, but it is more likely that it falls somewhere in between the 62%-90% window... Not a ton of transparency was given on the results.
The half dose + full dose regimen that had higher efficacy (relative to full dose + full dose) had a much smaller number of participants.
It also just doesn't make intuitive sense that half dose + full dose would work materially better than full dose + full dose. The actual number is likely somewhere in between 62%-90%.
I mean, it does when you are talking about mitigating an immune system response.